Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets

Diabetes

Volumn 55, Issue 5, 2006, Pages 1223-1231

  López Avalos, María D ^a,b   Duvivier Kali, Valérie F ^a,c   Xu, Gang ^a,d   Bonner Weir, Susan ^a   Sharma, Arun ^a   Weir, Gordon C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c SANOFI   (France)

^d LifeScan   (United States)

Author keywords

E6 AP, E6 associated protein; NF B, nuclear factor B; PGP9.5, protein gene product 9.5; PKC, protein kinase C; TRCP, transducin repeat containing protein

Indexed keywords

CD45 ANTIGEN; GLUCOSE; LACTACYSTIN; PROTEASOME; PROTEASOME INHIBITOR; UBIQUITIN; CYSTEINE PROTEINASE; PRIMER DNA; UBIQUITIN THIOLESTERASE; UCHL1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION; ENZYMOLOGY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CYSTEINE ENDOPEPTIDASES; DNA PRIMERS; ISLETS OF LANGERHANS; POLYMERASE CHAIN REACTION; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UBIQUITIN; UBIQUITIN THIOLESTERASE;

EID: 33745322750     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db05-0450     Document Type: Article

References (52)

1. Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem 67:425-479, 1998
2. Weissman AM: Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2:169-178, 2001
3. Hicke L: Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol 9:107-112, 1999
4. Strous GJ, Govers R: The ubiquitin-proteasome system and endocytosis. J Cell Sci 112:1417-1423, 1999
5. Koepp DM, Harper JW, Elledge SJ: How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97:431-434, 1999
6. Laney JD, Hochstrasser M: Substrate targeting in the ubiquitin system. Cell 97:427-430, 1999
7. Lee DH, Goldberg AL: Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 8:397-403, 1998
8. Lam YA, Xu W, DeMartino GN, Cohen RE: Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 385:737-740, 1997
9. Wilkinson KD: Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin Cell Dev Biol 11:141-148, 2000
10. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J: The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246:670-673, 1989
11. Jentsch S: A pseudogene for a novel ubiquitin C-terminal hydrolase of S. cerevisiae. Nucleic Acid Res 19:1147, 1991
12. Zhang N, Wilkinson K, Bownes M: Cloning and analysis of expression of a ubiquitin carboxyl terminal hydrolase expressed during oogenesis in Drosophila melanogaster. Dev Biol 157:214-223, 1993
13. Larsen CN, Krantz BA, Wilkinson KD: Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37:3358-3368, 1998
14. Sreenan SK, Zhou Y-P, Otani K, Hansen PA, Currie KPM, Pan C-Y, Lee J-P, Ostrega DM, Pugh W, Horikawa Y, Cox NJ, Hanis CL, Burant CF, Fox AP, Bell GI, Polonsky KS: Calpains play a role in insulin secretion and action. Diabetes 50:2013-2020, 2001
15. Zhou YP, Sreenan S, Pan CY, Currie KP, Bindokas VP, Horikawa Y, Lee JP, Ostrega D, Ahmed N, Baldwin AC, Cox NJ, Fox AP, Miller RJ, Bell GI, Polonsky KS: A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 52:528-534, 2003
16. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175, 2000
17. Saric T, Muller D, Seitz HJ, Pavelic K: Non-covalent interaction of ubiquitin with insulin-degrading enzyme. Mol Cell Endocrinol 204:11-20, 2003
18. Sternesjo J, Karlsen AE, Sandler S: Involvement of the proteasome in IL-1beta induced suppression of islets of Langerhans in the rat. Ups J Med Sci 108:37-50, 2003
19. Laybutt DR, Kaneto H, Hasenkamp W, Grey S, Jonas J-C, Sgroi DC, Groff A, Ferran C, Bonner-Weir S, Sharma A, Weir GC: Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to β-cell survival during chronic hyperglycemia. Diabetes 51:413-423, 2002
20. Leahy JL, Bonner-Weir S, Weir GC: Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81:1407-1414, 1988
21. Gotoh M, Maki T, Satomi S, Porter J, Bonner-Weir S, O'Hara CJ, Monaco AP: Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation 43:725-730, 1987
22. Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S, Weir GC: Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 274:14112-14121, 1999
23. Day IN, Thompson RJ: Molecular cloning of cDNA coding for human PGP 9.5 protein: a novel cytoplasmic marker for neurones and neuroendocrine cells. FEBS Lett 210:157-160, 1987
24. Kajimoto Y, Hashimoto T, Shirai Y, Nishino N, Kuno T, Tanaka C: cDNA cloning and tissue distribution of a rat ubiquitin carboxyl-terminal hydrolase PGP9.5. J Biochem (Tokyo) 112:28-32, 1992
25. Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J: PGP 9.5: a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 278:224-228, 1983
26. Yokoyama-Hayashi K, Takahashi T, Kakita A, Yamashina S: Expression of PGP9.5 in ductal cells of the rat pancreas during development and regeneration: can it be a marker for pancreatic progenitor cells? Endocr J 49:61-74, 2002
27. Liu YQ, Nevin PW, Leahy JL: Beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia. Am J Physiol Endocrinol Metab 279:E68-E73, 2000
28. Wilson PO, Barber PC, Hamid QA, Power BF, Dhillon AP, Rode J, Day IN, Thompson RJ, Polak JM: The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol 69:91-104, 1988
29. Rode J, Dhillon AP, Doran JF, Jackson P, Thompson RJ: PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology 9:147-158, 1985
30. Power RF, Holm R, Bishop AE, Varndell IM, Alpert S, Hanahan D, Polak JM: Transgenic mouse model: a new approach for the investigation of endocrine pancreatic B-cell growth. Gut 28:121-129, 1987
31. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD: Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161:153-160, 1990
32. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME: Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 21:516-520, 1998
33. Hull RL, Westermark GT, Westermark P, Kahn SE: Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89:3629-3643, 2004
34. O'Brien TD, Butler AE, Roche PC, Johnson KH, Butler PC: Islet amyloid polypeptide in human insulinomas: evidence for intracellular amyloidogenesis. Diabetes 43:329-336, 1994
35. Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, Wada K: Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 23:47-51, 1999
36. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH: The ubiquitin pathway in Parkinson's disease. Nature 395:451-452, 1998
37. Huynh DP, Dy M, Nguyen D, Kiehl TR, Pulst SM: Differential expression and tissue distribution of parkin isoforms during mouse development. Brain Res Dev Brain Res 130:173-181, 2001
38. Tiedge M, Lortz S, Drinkgern J, Lenzen S: Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733-1742, 1997
39. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y: Hyperglycemia causes oxidative stress in pancreatic β-cells of GK rats, a model of type 2 diabetes. Diabetes 48:927-932, 1999
40. Haass C, Kahle PJ: Neuroscience: parkin and its substrates. Science 293:224-225, 2001
41. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T: Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25:302-305, 2000
42. Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, Rommens JM, Beaudet AL: De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 15:74-77, 1997
43. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T: The ubiquitin-proteasome pathway is required for processing the NF- kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773-785, 1994
44. Scheffner M, Huibregtse JM, Howley PM: Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc Natl Acad Sci U S A 91:8797-8801, 1994
45. Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC: The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286:309-312, 1999
46. Thien CB, Langdon WY: Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2:294-307, 2001
47. Kalbe L, Leunda A, Sparre T, Meulemans C, Ahn MT, Orntoft T, Kruhoffer M, Reusens B, Nerup J, Remacle C: Nutritional regulation of proteases involved in fetal rat insulin secretion and islet cell proliferation. Br J Nutr 93:309-316, 2005
48. Kitiphongspattana K, Mathews CE, Leiter EH, Gaskins HR: Proteasome inhibition alters glucose-stimulated (pro) insulin secretion and turnover in pancreatic {beta}-cells. J Biol Chem 280:15727-15734, 2005
49. Checler F, da Costa CA, Ancolio K, Chevallier N, Lopez-Perez E, Marambaud P: Role of the proteasome in Alzheimer's disease. Biochim Biophys Acta 1502:133-138, 2000
50. Hicke L: A new ticket for entry into budding vesicles-ubiquitin. Cell 106:527-530, 2001
51. Henquin JC: Cell biology of insulin secretion. In Joslin Diabetes Mellitus. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1994
52. Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA: Activation of protein kinase C triggers its ubiquitination and degradation. Mol Cell Biol 18:839-845, 1998